The contrasting phylodynamics of human influenza B viruses

  1. Dhanasekaran Vijaykrishna  Is a corresponding author
  2. Edward C Holmes
  3. Udayan Joseph
  4. Mathieu Fourment
  5. Yvonne C F Su
  6. Rebecca Halpin
  7. Raphael T C Lee
  8. Yi-Mo Deng
  9. Vithiagaran Gunalan
  10. Xudong Lin
  11. Timothy B Stockwell
  12. Nadia B Fedorova
  13. Bin Zhou
  14. Natalie Spirason
  15. Denise Kühnert
  16. Veronika Boskova
  17. Tanja Stadler
  18. Anna-Maria Costa
  19. Dominic E Dwyer
  20. Q Sue Huang
  21. Lance C Jennings
  22. William Rawlinson
  23. Sheena G Sullivan
  24. Aeron C Hurt
  25. Sebastian Maurer-Stroh
  26. David E Wentworth
  27. Gavin J D Smith
  28. Ian Barr
  1. Duke-NUS Graduate Medical School, Singapore
  2. University of Sydney, Australia
  3. J Craig Venter Institute, United States
  4. Agency for Science, Technology and Research, Singapore
  5. Peter Doherty Institute for Infection and Immunity, Australia
  6. Eidgenössische Technische Hochschule Zürich, Switzerland
  7. Royal Children's Hospital, Australia
  8. Westmead Hospital, Australia
  9. National Centre for Biosecurity and Infectious Disease, New Zealand
  10. Canterbury Health Laboratories, New Zealand
  11. Prince of Wales Hospital, Australia
  12. Peter Doherty Institute for Infection and Immunity, United States

Abstract

A complex interplay of viral, host and ecological factors shape the spatio-temporal incidence and evolution of human influenza viruses. Although considerable attention has been paid to influenza A viruses, a lack of equivalent data means that an integrated evolutionary and epidemiological framework has until now not been available for influenza B viruses, despite their significant disease burden. Through the analysis of over 900 full genomes from an epidemiological collection of more than 26,000 strains from Australia and New Zealand, we reveal fundamental differences in the phylodynamics of the two co-circulating lineages of influenza B virus (Victoria and Yamagata), showing that their individual dynamics are determined by a complex relationship between virus transmission, age of infection and receptor binding preference. In sum, this work identifies new factors that are important determinants of influenza B evolution and epidemiology.

Article and author information

Author details

  1. Dhanasekaran Vijaykrishna

    Duke-NUS Graduate Medical School, Singapore, Singapore
    For correspondence
    vijay.dhanasekaran@duke-nus.edu.sg
    Competing interests
    The authors declare that no competing interests exist.
  2. Edward C Holmes

    Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Udayan Joseph

    Duke-NUS Graduate Medical School, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  4. Mathieu Fourment

    Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Yvonne C F Su

    Duke-NUS Graduate Medical School, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  6. Rebecca Halpin

    J Craig Venter Institute, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Raphael T C Lee

    Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  8. Yi-Mo Deng

    World Health Organisation Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Vithiagaran Gunalan

    Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  10. Xudong Lin

    J Craig Venter Institute, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Timothy B Stockwell

    J Craig Venter Institute, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Nadia B Fedorova

    J Craig Venter Institute, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Bin Zhou

    J Craig Venter Institute, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Natalie Spirason

    World Health Organisation Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  15. Denise Kühnert

    Department of Environmental Systems Science, Eidgenössische Technische Hochschule Zürich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  16. Veronika Boskova

    Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zürich, Basel, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  17. Tanja Stadler

    Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zürich, Zurich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  18. Anna-Maria Costa

    Royal Children's Hospital, Parkville, Australia
    Competing interests
    The authors declare that no competing interests exist.
  19. Dominic E Dwyer

    Centre for Infectious Diseases and Microbiology Laboratory Services, Westmead Hospital, Westmead, Australia
    Competing interests
    The authors declare that no competing interests exist.
  20. Q Sue Huang

    Institute of Environmental Science and Research, National Centre for Biosecurity and Infectious Disease, Upper Hutt, New Zealand
    Competing interests
    The authors declare that no competing interests exist.
  21. Lance C Jennings

    Microbiology Department, Canterbury Health Laboratories, Christchurch, New Zealand
    Competing interests
    The authors declare that no competing interests exist.
  22. William Rawlinson

    Virology Division, SEALS Microbiology, Prince of Wales Hospital, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  23. Sheena G Sullivan

    World Health Organisation Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  24. Aeron C Hurt

    World Health Organisation Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  25. Sebastian Maurer-Stroh

    Bioinformatics Institute, Agency for Science, Technology and Research, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  26. David E Wentworth

    J Craig Venter Institute, Rockville, United States
    Competing interests
    The authors declare that no competing interests exist.
  27. Gavin J D Smith

    Duke-NUS Graduate Medical School, Singapore, Singapore
    Competing interests
    The authors declare that no competing interests exist.
  28. Ian Barr

    World Health Organisation Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, United States
    Competing interests
    The authors declare that no competing interests exist.

Copyright

© 2015, Vijaykrishna et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,090
    views
  • 1,040
    downloads
  • 179
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Dhanasekaran Vijaykrishna
  2. Edward C Holmes
  3. Udayan Joseph
  4. Mathieu Fourment
  5. Yvonne C F Su
  6. Rebecca Halpin
  7. Raphael T C Lee
  8. Yi-Mo Deng
  9. Vithiagaran Gunalan
  10. Xudong Lin
  11. Timothy B Stockwell
  12. Nadia B Fedorova
  13. Bin Zhou
  14. Natalie Spirason
  15. Denise Kühnert
  16. Veronika Boskova
  17. Tanja Stadler
  18. Anna-Maria Costa
  19. Dominic E Dwyer
  20. Q Sue Huang
  21. Lance C Jennings
  22. William Rawlinson
  23. Sheena G Sullivan
  24. Aeron C Hurt
  25. Sebastian Maurer-Stroh
  26. David E Wentworth
  27. Gavin J D Smith
  28. Ian Barr
(2015)
The contrasting phylodynamics of human influenza B viruses
eLife 4:e05055.
https://doi.org/10.7554/eLife.05055

Share this article

https://doi.org/10.7554/eLife.05055

Further reading

    1. Ecology
    2. Evolutionary Biology
    Rebecca D Tarvin, Jeffrey L Coleman ... Richard W Fitch
    Research Article

    Understanding the origins of novel, complex phenotypes is a major goal in evolutionary biology. Poison frogs of the family Dendrobatidae have evolved the novel ability to acquire alkaloids from their diet for chemical defense at least three times. However, taxon sampling for alkaloids has been biased towards colorful species, without similar attention paid to inconspicuous ones that are often assumed to be undefended. As a result, our understanding of how chemical defense evolved in this group is incomplete. Here, we provide new data showing that, in contrast to previous studies, species from each undefended poison frog clade have measurable yet low amounts of alkaloids. We confirm that undefended dendrobatids regularly consume mites and ants, which are known sources of alkaloids. Thus, our data suggest that diet is insufficient to explain the defended phenotype. Our data support the existence of a phenotypic intermediate between toxin consumption and sequestration — passive accumulation — that differs from sequestration in that it involves no derived forms of transport and storage mechanisms yet results in low levels of toxin accumulation. We discuss the concept of passive accumulation and its potential role in the origin of chemical defenses in poison frogs and other toxin-sequestering organisms. In light of ideas from pharmacokinetics, we incorporate new and old data from poison frogs into an evolutionary model that could help explain the origins of acquired chemical defenses in animals and provide insight into the molecular processes that govern the fate of ingested toxins.

    1. Computational and Systems Biology
    2. Evolutionary Biology
    Pierre Barrat-Charlaix, Richard A Neher
    Research Article

    As pathogens spread in a population of hosts, immunity is built up, and the pool of susceptible individuals are depleted. This generates selective pressure, to which many human RNA viruses, such as influenza virus or SARS-CoV-2, respond with rapid antigenic evolution and frequent emergence of immune evasive variants. However, the host’s immune systems adapt, and older immune responses wane, such that escape variants only enjoy a growth advantage for a limited time. If variant growth dynamics and reshaping of host-immunity operate on comparable time scales, viral adaptation is determined by eco-evolutionary interactions that are not captured by models of rapid evolution in a fixed environment. Here, we use a Susceptible/Infected model to describe the interaction between an evolving viral population in a dynamic but immunologically diverse host population. We show that depending on strain cross-immunity, heterogeneity of the host population, and durability of immune responses, escape variants initially grow exponentially, but lose their growth advantage before reaching high frequencies. Their subsequent dynamics follows an anomalous random walk determined by future escape variants and results in variant trajectories that are unpredictable. This model can explain the apparent contradiction between the clearly adaptive nature of antigenic evolution and the quasi-neutral dynamics of high-frequency variants observed for influenza viruses.